Cargando…

A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany

BACKGROUND: Control of the 2019 coronavirus disease (COVID-19) pandemic in Germany and return to pre-pandemic behaviour can only be achieved through natural or vaccine-induced immunity. Sufficient vaccine capacity promotes interest in the necessary and feasible target vaccination coverage. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Waize, M, Scholz, S, Schmid-Küpke, N, Koch, J, Vygen-Bonnet, S, Harder, T, Wichmann, O
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620203/
http://dx.doi.org/10.1093/eurpub/ckac129.667
_version_ 1784821319741734912
author Waize, M
Scholz, S
Schmid-Küpke, N
Koch, J
Vygen-Bonnet, S
Harder, T
Wichmann, O
author_facet Waize, M
Scholz, S
Schmid-Küpke, N
Koch, J
Vygen-Bonnet, S
Harder, T
Wichmann, O
author_sort Waize, M
collection PubMed
description BACKGROUND: Control of the 2019 coronavirus disease (COVID-19) pandemic in Germany and return to pre-pandemic behaviour can only be achieved through natural or vaccine-induced immunity. Sufficient vaccine capacity promotes interest in the necessary and feasible target vaccination coverage. METHODS: An age and risk group stratified SEIR transmission model was used to assess the impact of vaccination coverage ranging 65%-95% for 12-59-year-olds and 90%-95% for ≥ 60-year-olds on COVID-19 incidence and intensive care unit (ICU) utilization between 01.07.2021-31.03.2022. Separate implementation of licensed vaccines allows to consider different efficacies, delivery rates and age-specific national vaccination recommendations. The analysis was conducted under different assumptions about contact behaviour during summer, reduction of daily contacts with increasing number of cases, daily vaccination uptake and the dominant variant. Data from the COVIMO study (N = 3004, data collection: 17.05.-09.06.2021) were used to define the population percentage willing to be vaccinated. RESULTS: The COVIMO study indicates an achievable vaccination compliance rate of 83.9% among 12-59-year-olds and 94.8% among those ≥ 60-year-olds. Maximum incidence or ICU utilization during observation period decreases from 385 to 61 and 6220 to 2800, respectively, with an increase in vaccination coverage from 65% to 95% of 12-59-year-olds, 90% vaccination rate among ≥ 60-year-olds, compared to pre-pandemic reduced contact behaviour in summer and reduction of contacts as case numbers increase. CONCLUSIONS: The vaccination campaign should be continued at high intensity until at least 85% of 12-59-year-olds or 90% of ≥ 60-year-olds are fully vaccinated against COVID-19. Based on the population's willingness to be vaccinated, this goal seemed feasible. KEY MESSAGES: • Mathematical modeling was used to determine an evidence-based target vaccination coverage of ≥ 85%. • Expertise in modeling should be further strengthened.
format Online
Article
Text
id pubmed-9620203
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96202032022-11-04 A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany Waize, M Scholz, S Schmid-Küpke, N Koch, J Vygen-Bonnet, S Harder, T Wichmann, O Eur J Public Health Parallel Programme BACKGROUND: Control of the 2019 coronavirus disease (COVID-19) pandemic in Germany and return to pre-pandemic behaviour can only be achieved through natural or vaccine-induced immunity. Sufficient vaccine capacity promotes interest in the necessary and feasible target vaccination coverage. METHODS: An age and risk group stratified SEIR transmission model was used to assess the impact of vaccination coverage ranging 65%-95% for 12-59-year-olds and 90%-95% for ≥ 60-year-olds on COVID-19 incidence and intensive care unit (ICU) utilization between 01.07.2021-31.03.2022. Separate implementation of licensed vaccines allows to consider different efficacies, delivery rates and age-specific national vaccination recommendations. The analysis was conducted under different assumptions about contact behaviour during summer, reduction of daily contacts with increasing number of cases, daily vaccination uptake and the dominant variant. Data from the COVIMO study (N = 3004, data collection: 17.05.-09.06.2021) were used to define the population percentage willing to be vaccinated. RESULTS: The COVIMO study indicates an achievable vaccination compliance rate of 83.9% among 12-59-year-olds and 94.8% among those ≥ 60-year-olds. Maximum incidence or ICU utilization during observation period decreases from 385 to 61 and 6220 to 2800, respectively, with an increase in vaccination coverage from 65% to 95% of 12-59-year-olds, 90% vaccination rate among ≥ 60-year-olds, compared to pre-pandemic reduced contact behaviour in summer and reduction of contacts as case numbers increase. CONCLUSIONS: The vaccination campaign should be continued at high intensity until at least 85% of 12-59-year-olds or 90% of ≥ 60-year-olds are fully vaccinated against COVID-19. Based on the population's willingness to be vaccinated, this goal seemed feasible. KEY MESSAGES: • Mathematical modeling was used to determine an evidence-based target vaccination coverage of ≥ 85%. • Expertise in modeling should be further strengthened. Oxford University Press 2022-10-25 /pmc/articles/PMC9620203/ http://dx.doi.org/10.1093/eurpub/ckac129.667 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Parallel Programme
Waize, M
Scholz, S
Schmid-Küpke, N
Koch, J
Vygen-Bonnet, S
Harder, T
Wichmann, O
A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
title A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
title_full A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
title_fullStr A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
title_full_unstemmed A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
title_short A dynamic transmission model to calculate vaccination coverage needed to control COVID-19 in Germany
title_sort dynamic transmission model to calculate vaccination coverage needed to control covid-19 in germany
topic Parallel Programme
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620203/
http://dx.doi.org/10.1093/eurpub/ckac129.667
work_keys_str_mv AT waizem adynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT scholzs adynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT schmidkupken adynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT kochj adynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT vygenbonnets adynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT hardert adynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT wichmanno adynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT waizem dynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT scholzs dynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT schmidkupken dynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT kochj dynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT vygenbonnets dynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT hardert dynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany
AT wichmanno dynamictransmissionmodeltocalculatevaccinationcoverageneededtocontrolcovid19ingermany